Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) is a Saudi Joint–Stock company with a fully paid-up capital of SR 600 million. Their main objective of setting up an advanced pharmaceutical industry in the Kingdom of Saudi Arabia is for the local production of medicines and medical appliances to market these products inside the Kingdom and for Export.
SPIMACO has developed a strong position in Saudi Arabia and is well positioned to sustain its growth and have a sound platform to serve export markets.
SPIMACO main manufacturing facility – Al–Qassim Pharmaceutical Plant was planned, constructed and equipped up to the highest quality levels. SPIMACO earned a lot of national quality awards and attained major international certifications.
SPIMACO's production started in the first quarter of 1990 with six products only and increased to over 150 products now. Production capabilities include the production of oral solids, oral liquids, dry powders, indictable, ointments, creams, suppositories, and various other forms. Fevadol, Histop, Betamet, Orasept are belongs to SPIMACO's fast moving product categories.